Published in
Wiley, American Journal of Hematology, 8(99), p. 1640-1643, 2024
DOI: 10.1002/ajh.27366
Links
Tools
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1‐ or IDH2‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study
Journal article published in 2024 by
Jan Philipp Bewersdorf 
,
Shai Shimony ,
Rory M. Shallis,
Yiwen Liu,
Guillaume Berton ,
Eva J. Schaefer,
Amer M. Zeidan,
Aaron Goldberg,
Eytan Stein,
Guido Marcucci,
Rebecca P. Bystrom,
R. Coleman Lindsley,
Evan C. Chen,
Jorge Ramos,
Anthony Stein
and other authors.
,
Shai Shimony ,
Rory M. Shallis,
Yiwen Liu,
Guillaume Berton ,
Eva J. Schaefer,
Amer M. Zeidan,
Aaron Goldberg,
Eytan Stein,
Guido Marcucci,
Rebecca P. Bystrom,
R. Coleman Lindsley,
Evan C. Chen,
Jorge Ramos,
Anthony Stein
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 